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Abstract 
Macrophages and dendritic cells are at the front line of defence against fungi, 
bacteria and viruses.  Together with physical barriers such as mucus, and a 
range of antimicrobial compounds they constitute a major part of the intrinsic and 
innate immune systems.  They have elaborate features, including pattern 
recognition receptors and specialized endocytic mechanisms, cytokines and 
chemokines, and the ability to call on reserves.  As masters of manipulation and 
counter-attack viruses shunt intrinsic and innate recognition, enter immune cells, 
and spread from these cells throughout an organism.  Here, we review recently 
described mechanisms by which viruses subvert endocytic and pathogen-
sensing functions of macrophages and dendritic cells, while highlighting possible 
strategic advantages of infecting cells normally tuned into pathogen destruction.  
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The cell biology of virus infection 
The use of cell biological and molecular techniques has enabled virologists to 
understand the interplay between viruses and cells at the heart of the infection 
process.  This is also shown in a recent surge of system-wide approaches, such 
as high-throughput RNAi screening, functional genomics or large-scale 
proteomics [for reviews, see 1, 2-4].  While these approaches are informing us 
about interactions between viruses and their host cells, for technical reasons, 
they have been performed in cell lines that may not be the major targets during 
natural infections.  In the past few years there has been a push towards novel 
approaches and the use of primary cell lines or tissue culture systems that more 
accurately reflect the situation viruses encounter in an organism.  This must 
involve the consideration of phagocytic cells, such as macrophages and dendritic 
cells (DCs).  A recent example for a non-autonomous action of macrophages in 
viral entry has been the finding that apical entry of human adenovirus (HAdV) 
into polarized epithelial cells is facilitated by macrophage-derived chemokines, 
such as CXCL-8 [5].  These cytokines are released from macrophages upon 
contacting the virus.  On highly polarized epithelial cells the cytokines trigger a 
redistribution of the viral entry receptors CAR and integrins from the basolateral 
to the apical membrane, thereby enabling infection from the luminal side of 
airways.  
 
The professionals: macrophages and DCs 
Why do macrophages and DCs take center stage for viral infections?  These 
cells are specialized immune cells located throughout the body.  By virtue of their 
fast chemotactic movements to sites of infection, they are often the first to 
encounter, identify, and engulf invading pathogens [6-10].  They decode the 
nature of the pathogen, and distinguish between soluble components of 
pathogens and the agents themselves, hence tuning inflammatory responses 
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[11].  Professional phagocytic cells generate reactive oxygen species highly toxic 
for pathogens, or they perforate membranes or digest invading pathogens by 
hydrolytic enzymes.   
The immune surveillance function of macrophages and DCs crucially depends on 
highly active endocytic processes [for reviews, see for example 7, 12].  This 
allows them to not only engulf and digest invading pathogens, but also present 
the products on their cell surface to T lymphocytes using major histocompatibility 
complex (MHC) molecules [reviewed in 11, 13].  T cells themselves produce 
soluble mediators, such as interferon gamma, which activate and enhance 
macrophage killing ability [14].  Macrophages and DCs fulfil two major functions 
in immunity, an innate and an adaptive function.  Through efficient ingestion and 
destruction, pathogens are eliminated from circulation within the body, and 
second, the displayed antigens act in the initiation of an adaptive immune 
response.  These events involve the production of cytokines, chemokines or 
reactive oxides, recruitment of other immune cells, and regulation of T cell 
activity and inflammation in response to the detected pathogen [11, 15, 16]. In 
the case of DCs these functions often overlap between subsets, with classical 
DCs being more efficient professional APCs and plasmacytoid DCs (pDCS), 
playing the role of the primary producer of type I interferon and pro-inflammatory 
cytokines in response to viral infection [17]. 
 
Endocytic mechanisms in macrophages and DCs 
Macrophages and classical DCs, referred to as DCs throughout, are professional 
phagocytes with exceptionally high endocytic activity.  Besides phagocytosis, 
they carry out pinocytosis, such as clathrin- and non-clathrin-mediated 
endocytosis and macropinocytosis (Figure 1).  These endocytic machineries are 
elaborate and deeply interconnected with signalling and the physiology of the 
particular cell type [for excellent reviews, see 18, 19-22].  The best understood 
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endocytic process is clathrin-mediated endocytosis (CME).  It is strictly receptor-
dependent and requires the coat protein clathrin, and the large GTPase dynamin 
for fission and release of clathrin-coated vesicles from the plasma membrane [23, 
24].  Clathrin-independent mechanisms in turn give rise to distinct endocytic 
pathways generally independent of dynamin, as schematized in Figure 1 [for 
reviews, see 25, 26].  Some of these pathways have been implicated in repair 
processes, for example upon membrane insults [27].   
Among the clathrin-independent pathways is macropinocytosis, a signal-induced 
transient actin-dependent process [18, 28].  In macrophages and DCs, however, 
macropinocytosis is wired as an on-going constitutive process [29, 30].  It is 
coupled to the migratory phenotype of these cells and essential for their immune 
function.   Macropinocytosis is strictly dependent on actin and Na+/H+ exchangers.  
Na+/H+ exchangers rectify the cytosolic acidic pH proximal to activated tyrosine 
kinase receptors near the plasma membrane, and thereby relieve inhibition of 
guanine nucleotide exchange factors of Rho family GTPase [31].   
Phagocytosis is mechanistically similar to macropinocytosis, albeit, unlike 
macropinocytosis, dependent on dynamin and a close apposition of a multivalent 
ligand with plasma membrane receptors [28, 32, 33].  It is key for maintaining 
tissue homeostasis and balancing innate and adaptive immune response to 
bacterial and fungal infections (Box 1).  Given that phagocytosis is specified for 
particles typically larger than 0.5-1 µm [34, 35], viruses smaller than 0.5 µm are 
taken up by endocytosis rather than phagocytosis.  Notable exceptions are 
reports for herpes simplex virus 1 (HSV-1) and Mimivirus [36, 37], or HAdV-C2 
aggregated by soluble receptor fragments and targeted to the high affinity Fc 
receptor CD64 of human monocytes [38].  The vacuolar compartments formed 
during pinocytosis, macropinocytosis and phagocytosis are classical endosomes, 
macropinosomes and phagosomes, respectively.  They follow similar maturation 
programs controlled by Rab GTPases and signalling phosphoinositide lipids [see 
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Figure 3, and 18, 33, 39].  Despite the similarities between these processes, we 
should keep in mind that pinocytosis, macropinocytosis and phagocytosis are 
tuned by specific machineries emerging from divergent receptor engagements 
and responses of subcellular networks [11, 40].  This leads to different forms of 
information processing and physiological reactions.   
 
Virus entry into macrophages and DCs 
Virus entry requires distinct cellular processes, typically attachment to receptors, 
signalling and movements of viruses on the cell surface, endocytic uptake and 
trafficking, and finally penetration and genome uncoating [for illustration, see 
Figure 2, and reviews by 41, 42, 43].  Despite their armaments, macrophages 
and DCs are not immune against viruses, and both DNA and RNA viruses can 
infect macrophages and/or DCs (Table 1).  This is not surprising, since viruses 
have co-evolved with their hosts [44]. Mammals, for example, do not exclusively 
rely on macrophages and DCs for defence, but possess other potent pathogen 
killers, such as neutrophils and natural killer cells, which mount rapid responses 
against infected cells [34, 45].  
 
Virus Receptors 
Virus attachment and receptor engagement on target cells have an important role 
in determining cell-type specificity and host range [reviewed in 46, 47].  A special 
feature of macrophages and DCs is the expression of pattern recognition 
receptors (PRRs), which function in pathogen detection and destruction [48].  
PRRs bind to pathogen-associated molecular patterns (PAMPs) and thereby 
distinguish between ‘self’ and ‘non-self’. PRRs present in macrophages and DCs 
include RIG-I-like receptors (RLRs) and Toll-like receptors (TLRs) [49, 50].  The 
cytoplasmic RLRs (RIG-I and MDA5), and endosome-associated TLRs (TLR3, 7, 
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and 9) serve to decode viral features, such as capsid structures or nucleic acids, 
and initiate a fine-tuned production of antiviral pro-inflammatory cytokines and 
type I interferon [51].  The TLRs can act together with another class of PRRs, the 
scavenger receptors, which mediate non-opsonic phagocytosis of pathogens, 
and modulate the inflammatory response to TLR agonists [52].   
Another set of PRRs comprises the C-type lectin receptors (CLRs) including 
mannose receptor, LSECtin (Liver and lymph node sinusoidal endothelial cell C-
type lectin), Siglec1, DC-SIGN (dendritic cell-specific intercellular adhesion 
molecule-3 grabbing non-integrin), and its homologue DC-SIGNR.  These 
receptors, present on both macrophages and DCs, are responsible for the 
recognition of viruses and other pathogens displaying the surface PAMP high-
mannose glycoproteins [53, 54]. Binding to these receptors leads to an innate 
immune response against these viruses [53, 55].  Interestingly, HIV, hepatitis C 
virus (HCV) or dengue virus can take advantage of DC-SIGN for attachment to 
cells (Table 1).  Using a collection of phleboviruses, including Rift Valley fever 
and Uukuniemi viruses (UUKV), a recent study found that virus engagement of 
DC-SIGN by UUKV initiates a signalling cascade resulting in endocytosis and 
trafficking of the virus-receptor complex and infection [56].  Phleboviruses from 
the family of bunyaviridae are arboviruses transmitted during a blood meal of 
arthropods, such as insects.  Dermal DCs are likely to be the first cells to 
encounter these viruses after delivery into the mammalian host.  DC-SIGN 
mediated the delivery of UUKV to early endosomes.  There the virus dissociated 
from the receptor and trafficked to late endosomes, where it penetrated to the 
cytosol, as shown by live cell fluorescence imaging experimentations.  Whether 
DC-SIGN serves as an authentic receptor for phleboviruses other than UUKV, if 
DC-SIGN-mediated phlebovirus endocytosis requires a co-receptor, and what 
kind of endocytic mechanism is activated for DC-SIGN-mediated virus 
internalization will require further investigation.  
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Avoiding destruction in lysosomes 
The endo-lysosomal system of macrophages and DCs is designed for pathogen 
destruction and antigen presentation [11, 34].  For a pathogen, the lysosome of 
an antigen-presenting cell (APC) is a most hostile intracellular environment.  It 
has extremely high proton concentrations (~pH 4.0), a combination of over 50 
different proteases, lipases, DNAses, and other hydrolases, and reactive oxygen-, 
nitrogen-, and chloride-species.  
So why would a virus take such a risk?  A likely answer is that endocytosis offers 
an evolutionary, immune-evasion advantage over direct fusion at the plasma 
membrane.  Most importantly, this includes the presentation of a range of pre-
existing or induced entry portals along a dynamically changing endocytic 
pathway [57].  Maturation of vesicular compartments provides a cargo, such as a 
virus with a plethora of cues, such as decreasing pH, proteases or inorganic ions 
[reviewed in 58, 59].  Such cues can trigger the uncoating of virus genomes [43], 
or enable virus release from hostile compartments [60].  It is thus not surprising 
that even viruses that can fuse their envelope with the host membrane at neutral 
pH, such as HIV-1, HSV, human cytomegalovirus (HCMV) or respiratory 
syncytial virus (RSV) use endocytosis to gain entry into appropriate host cells 
[61-65].   
A pathway of emerging interest for virus entry into immune cells is 
macropinocytosis [28, 39].  This has been shown for HAdV of the species B [66, 
67], and vaccinia virus (VACV) mature- and extracellular- virions (MVs and EVs) 
in many different cell types [reviewed in 68].  A recent small compound inhibitor 
and localization study revealed that entry of both forms of VACV into monocyte-
derived DCs (MDDCs) occurs by macropinocytosis, independent of the C-type 
lectin receptors [69].  Consistent with macropinocytic uptake, entry of virus 
particles was dependent on actin, Na+/H+ exchangers, phosphoinositide 3-kinase, 
intracellular calcium, and cholesterol.  Just as important, entry was independent 
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of Fc- and complement receptors, clathrin, caveolin-1 and dynamin-2.  
Interestingly, after internalization virus did not co-localize with classical endocytic 
markers including EEA1 and Lamp2, or require low pH for fusion.  Since this 
pathway is constitutive in non-activated macrophages and DCs, it would not 
require the use of a particular receptor for cell activation but rather be provided a 
‘free ride’ into the cell.   
Although the ride is free for a virus, macropinocytic cargo can in fact be 
processed and presented on MHC I molecules [70], albeit not on MHC II [71].  
Hence, viral escape from macropinosomes prior to lysosome fusion may be 
important for the avoidance of processing and reduced MHC I/II presentation.  In 
line with this, delayed degradation of HIV-1 has been observed to occur upon 
macropinocytic uptake into macrophages [72].  In addition, as macropinosomes 
mature in parallel rather than merge into existing trafficking pathways, they may 
not expose the virus to the full repertoire of detection and destruction 
mechanisms present in classical endosomes and phagosomes.  In fact, there is 
currently no evidence that endosome and phagosome associated TLRs are 
present in macropinosomes.  
In summary, a number of important human pathogens infecting macrophages 
and DCs (Table 1) utilize macropinocytosis for entry into other cells types, for 
example HIV, influenza A virus, Ebola, Kaposi’s sarcoma-associated virus 
(KSHV) and HAdV [66, 67, 73-79].  It will be of importance to determine if these 
and other viruses are using macropinocytosis to enter APCs, and if so, what 
consequences for infection and pathogen detection this may provide.   
 
Autophagy – anti-viral and pro-viral 
Macrophages and DCs respond to invading viruses by inducing autophagy, a 
process operating in close association with endosomal functions.  The best 
studied autophagic process in immune cells is macroautophagy.  This process 
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involves the formation of a cytosolic double-membrane which engulfs 
cytoplasmic material resulting in a new vesicle, termed an autophagosome [80].  
Engulfed material can be degraded upon autophagosome fusion with late 
endosomes or lysosomes.  It is becoming increasingly clear that 
macroautophagy and innate immune recognition modulate each other, to 
facilitate pathogen elimination in both professional and non-professional immune 
cells [81].  For example, the detection of extracellular pathogens by TLRs up-
regulates macroautophagy in mouse macrophage cell lines [82].  More 
specifically, pathogen elimination can occur by enhanced degradation of viral 
proteins or nucleic acids [83], by tinkering with the balance between cell death 
and survival of infected and bystander cells [84], through channelling cytosolic 
viral components to endosomal TLRs in plasmacytoid dendritic cells [85], or by 
feeding antigens to MHC class II compartments for activation of adaptive 
immunity [86].  On the other hand, viruses using the cytosol for transit or 
replication have adapted a multitude of strategies to subjugate macroautophagy. 
For example, to supply membrane for viral replication, to enhance cell survival or 
suppress cell death [reviewed in 87].  Further research is clearly needed to 
untangle the benefits and liabilities of macroautophagy for both viral pathogens 
and hosts, and to place these results into the context of viral endocytosis. 
 
Virus infiltration, hiding, and killing  
As discussed above, virus entry into macrophages and DCs may be a risky 
venture for a virus.  Yet, viruses have come up with divergent ways to turn the 
tables on these sentinel cells [88].  For example, they modulate cytokine 
secretion or reduce antigen presentation, alter cellular trafficking, undergo 
latency or productive infection, and even interfere with cell death.  Rather than 
discussing the underlying mechanisms, we highlight three general strategies for 
infiltration, hiding and killing APCs (Figure 4).  
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Infiltration  
In some cases, virus infection of DCs causes their activation and lowers their 
endocytic capacity thus shunting surveillance.  Once activated by infection DCs 
migrate to the lymph nodes. Interestingly, several viruses that productively infect 
these cells take advantage of this process to facilitate virus spread.  Both Ebola 
and HIV-1 infections result in partial maturation of DCs while promoting their 
migration [89, 90].   
It is thought that HIV-1 uses DCs as a ‘Trojan horse’ for transport to lymph nodes 
where it infects CD4 T cells.  Unlike DCs, CD4 T cells are major targets of HIV-1 
for progeny production.  T cell infection through DCs can occur by budding of 
virions from DCs and cell-free transmission.  T cells can also be infected through 
DC-mediated cell-to-cell transmission via an immune-protective viral synapse, a 
process called trans-infection [91].  Trans-infection from immature DCs was 
suggested to require DC-SIGN [92] or other C-type lectins [93], although this was 
later found to be highly inefficient due to rapid degradation of virions after uptake 
[94, 95]. Conversely, trans-infection from mature DCs that relies on the CLR 
Siglec-1, rather than DC-SIGN, occurs efficiently [96]. In both cases these factors 
serve to capture but not promote virion fusion. In the simplest scenario, the 
captured HIV-1 is transferred directly to CD4 T-cells [97].  However, trans-
infection has also been reported to involve macropinocytic internalization and 
subsequent regurgitation of virions by DCs [91, 98, 99].  Although up for debate 
[100], the internalization of virions may serve to effectively hide virions prior to 
trans-infection.  Perhaps targeted exocytosis provides specific release of a large 
number of virions to the viral synapse only after formation of this immune-
protective environment has occurred.  However there are still many questions 
regarding the mechanism of trans-infection, above all no in vivo evidence of this 
process has been documented.   
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Hiding  
Perhaps the best strategy for long-term viral survival is to simply hide from, rather 
than attack, host defences as evidenced by several chronic human viruses such 
as HIV-1, HCV or KSHV.  These viruses can be latent, interfere with antigen 
processing and presentation, prevent APC maturation, or alter cytokine secretion 
[for a review, see 88].  Latency is most effective. It minimizes viral gene 
expression and under appropriate conditions, such as the encounter of a DC, can 
lead to viral gene expression from the latently integrated provirus in activated T 
cells [101].  For non-latent viruses the use of virus encoded proteins to prevent 
APC maturation and cytokine secretion is a common strategy [reviewed in 102].  
The VP35 protein of Ebola virus, for example, has been demonstrated to be a 
multifunctional protein with immunosuppressive functions including inhibition of 
DC maturation and prevention of T cell activation [102, 103].  It effectively blocks 
the link between the innate and adaptive immune response during infection.  
Consistent with these reports, infection with some Ebola virus strains, such as 
Zaire, can be associated with a mortality rate approaching 90% [104], while 
Ebola virus lacking VP35 does not cause lethality [105].  These studies 
emphasize the importance of virus-encoded immune modulators to the outcome 
of infection. 
 
Killing  
Given their important immunological role macrophages and DCs would be 
expected to be prime targets for elimination by invading pathogens.  However, 
only a few viruses, such as VACV or HSV-1 do so.  Infection by these viruses 
triggers apoptosis of DCs [106, 107].  In these cases infection is abortive, but 
results in inhibition of DC maturation, antigen presentation, and subsequent T 
cell activation.  The viral interference with DC function is crucial, since uninfected 
DCs can effectively activate T cells using antigens obtained by clearance of 
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infected apoptotic cells, for example in the case of HSV-1 or influenza A virus 
(IAV) [107, 108].  By killing of DCs, VACV and HSV-1 effectively reduce the 
number of APCs that can respond to the infection.  That these cells no longer 
mature or secrete cytokines is likely to shunt the recruitment of additional 
immune cells to the site of infection.  Additionally, as these cells are unable to 
activate T cells or migrate to secondary lymphoid tissue the activation of the 
adaptive immune response is likely slowed.  
 
Concluding remarks 
Multiple layers of cell defense control viral infections in an individual.  
Professional phagocytic DCs and macrophages are at the front line of this 
defense.  Their phagocytic activities are key to activate natural killer cells, and 
limit the initial viremia prior to initiation of B and T cell mediated adaptive 
immunity.  Further, DCs can cross-present viral antigens from infected B cells for 
T cell stimulation, and this may be key for virus-specific immune control. 
Neutralizing antibodies in turn control the plasma levels of viruses particularly 
upon lytic infections.  To date in depth knowledge of virus entry and infection in 
macrophages and DCs is limited to only a subset of viral pathogens.  It will be 
important to elucidate the major endocytic mechanisms used by viruses to enter 
macrophages and DCs, and how these pathways are linked to autophagy, an 
immediate antiviral activity within pathogen-sensing cells.  It will be interesting to 
consider the different types of dendritic cells and macrophages within tissues 
exposed to pathogens, such as the lung. Focus will need to be placed on 
elucidating their virus interaction biology and innate responses in isolation or 
tissue context [109].  All of this can serve as a basis to determine how these 
pathways are linked to innate immunity and eventually immune evasion.  Future 
work will also have to be directed at better understanding the in vivo implications 
of these findings. 
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Figure legends 
Figure 1. Endocytic mechanisms.  
The endocytic activities executed by cells are classified into pinocytic, 
macropinocytic, or phagocytic mechanisms.  The various pinocytic mechanisms 
are classified based on their cellular requirements, that is, dynamin or actin.  For 
each mechanism the major players are listed (in bold).  While a major fraction of 
studies have been conducted to understand clathrin-mediated, macropinocytic 
and phagocytic mechanisms in non-professional phagocytes, professional 
phagocytes may use the full range of endocytic mechanisms.  Although not fully 
understood, it is likely that viruses have learned to subjugate the majority of 
these pathways for infection of both professional and non-professional 
phagocytes. 
Figure 2. A classical virus entry program.  
The entry of a virus into a cell is a complex multi-step program involving a 
multitude of cellular and viral factors.  After initial binding viruses often transit the 
cell surface in search of their preferred receptor.  For direct penetration, receptor 
binding may result in a series of changes in the virus fusion machinery that 
facilitate its activation to promote fusion with the plasma membrane and delivery 
of the virus capsid into the host cytosol.  In the case of endocytosis, receptor 
engagement causes the host cell to respond through the induction of a signaling 
cascade that initiates endocytic uptake of the virus itself.  The passage through 
endosomes then provides cues for virus penetration.  In both scenarios, free 
virus capsids are transported to the site of viral genome uncoating, for example 
in a microtubule-dependent fashion.  The final stage of virus entry is the 
complete uncoating of the viral genome, which can occur either in the cytoplasm 
or the nucleus. 
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Figure 3. Endosomal trafficking and antigen presentation. 
Presented are the organelles associated with the main endocytic mechanisms at 
work in macrophages and DCs.  The classic endocytic pathway is responsible for 
trafficking of cargoes derived from clathrin- and non-clathrin- mediated 
endocytosis.  The organelles associated with this pathway are early endosomes 
(EEs), late endosomes (LEs), and lysosomes (LYs).  The maturation program of 
these organelles, consisting of changes in Rab (Ras related in brain) proteins 
and lipid-composition profiles, as well as a gradual lowering of pH, and their 
centripetal trafficking are relatively well defined.  Both macropinosomes and 
phagosomes mature in a fashion parallel to that of classical endosomes, going 
through distinct early macropinosomes (EM), early phagosomes (EP) and late 
macropinosomes (LM), late phagosomes (LP) stages.  All of the pathways 
converge at the level of lysosome fusion where upon incoming pathogens are 
destroyed and ultimately presented as antigenic non-self peptides at the cell 
surface in the context of MHC class I and II.  Whether phagolysosomal and 
macrolysosomal organelles are identical or represent distinct entities remains 
unknown.   
Figure 4. Virus exploitation of DC infection.  
Often virus infection of immature DCs stimulates their activation.  If everything 
were to go to plan this would result in a maturation program marked by the 
expression of cell surface molecules which signal that a possible invader has 
been detected.  This includes the cell surface expression of maturation markers 
(CD80/CD40), induction of DC migration to the lymph through up-regulation of 
CCR7, the release of cytokines to attract and stimulate the activity of additional 
immune cells, and the processing and presentation of antigen which in turn 
drives T cell activation.  However, viruses have devised multiple strategies to 
prevent the full assault from DCs and slow the activation of the adaptive immune 
response.  These include infiltrating, hiding, and in some cases killing of infected 
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DCs.  Infiltration is used by some viruses to rapidly spread infection to additional 
target cells, such as T cells.  In this scenario, maturation, antigen presentation, 
and cytokine secretion is shunted, while migration of the infected DCs is 
unabated.  Depending on the virus, infection can be productive, or virions can be 
captured on the cell surface and passed along.  Another strategy used by viruses 
to subvert DCs is hiding.  Given the number of successful chronic human 
infections that practice hiding, it is probably the most successful mechanism.  In 
most cases the viral infection results in latency or only low-level productive 
infection.  As seen during infiltration DC maturation, antigen presentation, and 
cytokine secretion are blocked by specific viral effectors.  Although only practiced 
by a few viruses, the most straight-forward strategy used by viruses to deal with 
DCs is killing.  In these cases, infection tends to be abortive and all facets of DC 
activation and maturation are attenuated. 
 
Box1. Phagocytosis 
Phagocytosis is one of the major endocytic mechanism employed by 
macrophages and dendritic cells for the uptake of large particulate matter.  It is a 
highly conserved, specialized endocytic mechanism involved in several essential 
functions including the anti-inflammatory clearance of apoptotic debris. While not 
typically involved in virus uptake, phagocytosis is essential for ingestion, 
destruction, and antigenic presentation of foreign pathogens, such as bacteria 
and fungi, underscoring its importance in innate immunity (for details, see main 
text).  
Particular features of phagocytosis include: 
 Exclusive to professional phagocytes (i.e. neutrophils, macrophages and 
dendritic cells). 
 Reserved for particles larger than 0.5-1 µm. 
 The particle being internalized drives phagosome size and shape.  
 Activation and uptake are site-specific. 
 Typically requires opsonins (i.e. immunoglobulin G and complement). 
 Can mediate pro- or anti-inflammatory responses depending on antigen. 
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Table 1. Viruses that infect DCs and macrophages 
 
Virus
a
 Genome/envelope (+/-)
b
 Productive
c
  Receptor(s)
d
 
Infections of DCs  
HIV-1 ssRNA+ (+) +/-  DC-SIGN 
SARS  ssRNA+ (+) + DC-SIGN 
HCV ssRNA+ (+) - CD81/CLDN1 
HRV6 ssRNA+ (-) - N.D. 
Ebola ssRNA-  (+) + NPC1 
Measles ssRNA-  (+)  + SLAM 
Dengue  ssRNA+ (+) + DC-SIGN 
RSV ssRNA-  (+) + N.D. 
Influenza A Segmented ssRNA- (+) +/- DC-SIGN 
Uukuniemi Segmented ssRNA- (+) + DC-SIGN 
Rift Valley fever Segmented ssRNA- (+) + DC-SIGN 
LCMV Segmented ssRNA- (+) + α-dystroglycan 
HBV ss/dsDNA (+) - NTCP 
Adenovirus dsDNA (-) + DC-SIGN/Lf 
HSV-1 dsDNA (+) - DC-SIGN 
HHV8/KSHV dsDNA (+) - DC-SIGN 
HCMV dsDNA (+) + DC-SIGN 
VZV dsDNA (+) + IDE 
EBV dsDNA (+) - N.D. 
Vaccinia dsDNA (+) - N.D. 
Infections of macrophages 
HIV-1 ssRNA+ (+) +/- DC-SIGN/ICAM3 
Ebola ssRNA-  (+) - NPC1 
RSV ssRNA-  (+) - N.D. 
Influenza A Segmented ssRNA- (+) +/- DC-SIGN 
 
a
Virus abbreviations: HIV-1, human immunodeficiency virus-1; SARS, sudden acute respiratory 
syndrome; HCV, hepatitis C virus; HRV6, human rhino virus 6; RSV, respiratory syncytial virus; 
LCMV, lymphocytic choriomeningitis virus; HBV, hepatitis B virus; HSV-1, herpes simplex virus-1; 
HHV8/KSHV, human herpes virus 8/Kaposi’s sarcoma herpes virus; HCMV, human 
cytomegalovirus; VZV, varicella-zoster virus; EBV, Epstein-Barr virus. 
b
Genome structure abbreviations: ss, single-stranded; ds, double stranded. For RNA genomes +/- 
indicates the sense of the RNA.  If the virus is enveloped (+) or non-enveloped (-) is indicated 
c
Whether virus infection is productive (+), non-productive (-), or varies depending on the literature  
(+/-) is indicated.   
d
Receptor abbreviations: DC-SIGN, dendritic cell-specific intercellular adhesion molecule-3-
grabbing non-integrin); CLDN1, claudin-1; NPC1, Niemann–Pick C1; SLAM, signalling 
lymphocyte-activation molecule; NTCP, sodium taurocholate cotransporting polypeptide; Lf, 
lactoferrin; IDE, insulin-degrading enzyme; ICAM3, intercellular adhesion molecule 3; N.D., not 
determined.  
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